ArticleFrontiers in pharmacology2025

A real-world disproportionality analysis of ripretinib data mining of the public version of FDA adverse event reporting system.

Yingkai Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.